Source: European Medicines Agency (EU) Revision Year: 2019 Publisher: Celgene Europe B.V., Winthontlaan 6 N, 3526 KV Utrecht, Netherlands
Thalidomide Celgene 50 mg hard capsules.
| Pharmaceutical Form |
|---|
|
Hard capsule. White opaque capsules marked “Thalidomide Celgene 50 mg”. |
Each capsule contains 50 mg of thalidomide.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Thalidomide |
Thalidomide shows immunomodulatory, anti-inflammatory and potential anti-neoplastic activities. Thalidomide is also a non-barbiturate centrally active hypnotic sedative. It has no antibacterial effects. |
| List of Excipients |
|---|
|
Capsule contents: Starch, pregelatinised Capsule shell: Gelatin Printing ink: Shellac |
PVC/PCTFE/aluminium blister containing 14 capsules.
Pack sizes: 28 capsules (two blisters) in a wallet card.
Celgene Europe B.V., Winthontlaan 6 N, 3526 KV Utrecht, Netherlands
EU/1/08/443/001
Date of first authorisation: 16 April 2008
Date of latest renewal: 08 February 2018
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
